Palboxen 125 mg - Palbociclib - Ibrance - Aio Pharma
Palboxen 125 mg (Palbociclib) sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of breast cancer.
Palboxen 125 mg (Palbociclib) sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of breast cancer.
Comments
Log in to comment or register here .